Amy Saunders
Lecturer
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (2)
γδ T cells are enriched at barrier sites such as skin, gut and lung, where they protect against cancer and infections and promote healing. They detect diverse ligands in T cell receptor-dependent or independent manners, producing large quantities of pro-inflammatory cytokines. γδ T cells develop in foetal thymi in temporally controlled waves where, unlike αβ T cells, many γδ T cells adopt their effector fate, becoming either IFNγ or IL-17A-producers (γδ17 T cells). CD200R1 suppresses myeloid cell activity but has also been shown to promote innate lymphoid cell IL-17A production, enhancing psoriasis-like skin inflammation. γδ17 T cells are potent IL-17A producers in skin therefore, the effect of CD200R1 on IL-17A production by γδ17 T cells was investigated. CD200R1 was found to promote IL-17A production by γδ T cells by supporting the development of γδ17 T cells, enhancing IL-17-producing and RORγt + γδ T cell numbers in foetal thymic organ cultures. To fulfil this role, CD200R1 acts either directly on developing γδ T cells, or indirectly on thymic stromal cells. This identifies CD200R1 as a critical novel regulator of γδ17 T cell development in early life, a key process for ensuring immunity, particularly at barrier sites.
Year:
2025
The glycocalyx is a proteoglycan-rich layer present on the surface of all mammalian cells that is particularly prevalent on endothelial cells lining the vasculature. It has been hypothesized that the glycocalyx mediates leukocyte migration by masking adhesion molecules and reducing leukocyte adhesion to the endothelium. Leukocyte recruitment is a key driver of inflammatory diseases, including the chronic skin disease, psoriasis. Here, we show that leukocytes express heparan sulfate, an important glycocalyx component, on their cell surface which is lost in response to psoriasis-like skin inflammation, whilst endothelial heparan sulfate expression is not affected. Treatment with a heparan sulfate mimetic during psoriasis-like skin inflammation protected heparan sulfate from cleavage by heparanase and resulted in reduced leukocyte accumulation in skin, yet unexpectedly, led to increased clinical signs of inflammation due to reduced Treg numbers. These findings reshape our understanding of immune cell recruitment by revealing the presence and function of a heparan sulfate glycocalyx on immune cells and highlight the complex effects of heparanase inhibitors on the immune response in this context. One Sentence Summary Leukocytes express a glycocalyx on their surface which is shed in response to psoriasis-like skin inflammation, facilitating their migration into the skin.
Year:
2024
Collaborators (4)
Iashia Nabi
The University of Manchester
Olga V. Zubkova
Programme Leader, Senior Scientist
Victoria University of Wellington
Shafqat Ahrar Jaigirdar
Lecturer
Sheffield Hallam University
Douglas Dyer
The University of Manchester
Make your next move.
Prepare your application
Review drafts before you send them.